The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.
 
Carla Casulo
Honoraria - Gilead Sciences
Research Funding - Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Melissa C. Larson
No Relationships to Disclose
 
Jonathan R Day
No Relationships to Disclose
 
Thomas Matthew Habermann
Consulting or Advisory Role - Celgene; Kite/Gilead
Research Funding - Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - BeiGene; Incyte; Loxo/Lilly; MorphoSys; Seagen; Tessa Therapeutics
 
Izidore S. Lossos
Honoraria - Janssen Biotech
Consulting or Advisory Role - Janssen Scientific Affairs; Seagen; Verastem
Research Funding - NCI
Patents, Royalties, Other Intellectual Property - Stanford- Royalties
 
Yucai Wang
Consulting or Advisory Role - Incyte (Inst); Innocare (Inst); Kite, a Gilead company (Inst); Loxo (Inst); TG Therapeutics (Inst)
Research Funding - Genentech (Inst); Incyte (Inst); InnoCare (Inst); Loxo (Inst); MorphoSys (Inst); Novartis (Inst)
 
Loretta J. Nastoupil
Honoraria - ADC Therapeutics; Bayer; Bristol-Myers Squibb; Celgene; Epizyme; Genmab; Gilead Sciences; Janssen Oncology; Morphosys; Novartis; Pfizer; Takeda; TG Therapeutics
Research Funding - Allogene Therapeutics; Caribou Biosciences; Celgene; Epizyme; Genentech/Roche; Gilead Sciences; IgM Biosciences; Janssen Biotech; Novartis; Takeda; TG Therapeutics
 
Christopher Strouse
Employment - Flagstaff Emergency Physicians (I); HCA Florida Healthcare (I)
Consulting or Advisory Role - Curio Science; GlaxoSmithKline
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Dai Chihara
Honoraria - AstraZeneca/Daiichi Sankyo
Research Funding - Bristol-Myers Squibb/Celgene
 
Peter Martin
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb/Celgene; Epizyme; Janssen; Karyopharm Therapeutics; Kite/Gilead; Merck; MorphoSys; Takeda; Verastem
Research Funding - Karyopharm Therapeutics (Inst)
 
Jonathon Brett Cohen
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Adicet Bio; Aptitude Medical; AstraZeneca; Janssen; Kite/Gilead; Loxo
Research Funding - AI Therapeutics (Inst); ASH (Inst); AstraZeneca (Inst); Bioinvent (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen (Inst); Loxo (Inst); Lymphoma Research Foundation (Inst); Novartis (Inst); Takeda (Inst)
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Celgene; Genentech; Genmab; Incyte; Janssen; Kite/Gilead; MEI Pharma; MorphoSys; Pharmacyclics; Roche
Research Funding - Acerta Pharma (Inst); ADC Therapeutics (Inst); Celgene (Inst); Genentech (Inst)
 
Jia Ruan
No Relationships to Disclose
 
Walter Richard Burack
No Relationships to Disclose
 
Jean Louise Koff
Consulting or Advisory Role - Gamida Cell; Janssen/Pharmacyclics; MorphoSys; TG Therapeutics
Research Funding - Atara Biotherapeutics; Celgene; Janssen/Pharmacyclics; Oncternal Therapeutics; Viracta Therapeutics
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
 
James Robert Cerhan
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene (Inst); Janssen; Janssen
Research Funding - Celgene (Inst); Genentech (Inst); NanoString Technologies (Inst)
(OPTIONAL) Uncompensated Relationships - Regeneron (Inst)
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Celgene; Denovo Biopharma; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Alimera Sciences (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millennium (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst); Xencor (Inst)
 
Brian K. Link
Consulting or Advisory Role - Genentech/Roche; MEI Pharma
Research Funding - Genentech/Abbvie (Inst); Pharmacyclics/Janssen (Inst)
 
Matthew J. Maurer
Employment - Exact Sciences (I)
Stock and Other Ownership Interests - Exact Sciences (I)
Consulting or Advisory Role - Adaptive Biotechnologies; Genmab; Kite, a Gilead company; MorphoSys; Pfizer
Research Funding - Celgene (Inst); Genentech (Inst); Morphosys (Inst); NanoString Technologies (Inst)